Medicaid

Medicaid appears in Howard Lutnick: How America Can Hit 6% GDP Growth in 2026 as both a drug-access program and a fraud-detection target. Howard Lutnick says Ozempic and Mounjaro would be available through Medicaid and Medicare at $149, and later says federal benefit programs should be compared against income to identify fraud.

The source makes Medicaid part of a broader fiscal-administration story: drug prices, welfare-state immigration costs, and benefit-integrity checks are all framed as ways to change government spending outcomes. The page keeps those claims source-attributed rather than treating the savings or eligibility effects as verified facts.

Connections

• CMS and HHS - agency context.
• Most-Favored-Nation Drug Pricing, Ozempic, and Mounjaro - drug-pricing branch.
• Government Benefit Fraud Matching - benefit-integrity branch.
• Merit-Based Immigration Filter - fiscal-contribution immigration frame connected in the episode.